drugset / Trial / NCT00004647
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy
Phase 3
Completed
40 enrolled
National Center for Research Resources (NCRR)
University of Tennessee · collab
RandomizedDouble-blindTreatment
Summary
OBJECTIVES: I. Assess the efficacy and toxicity of mexiletine in the management of paresthesias and pain in patients with diabetic neuropathy.
Timeline
- Start
- 1993-03
- Primary completion
- —
- Completion
- 1999-02
Publications
- Background Bertorini TE, Alzagatiti BI, Horner LH, et al.: Electrophysiological effects of mexiletine in painful neuropathy. Nerve 21(11): 1576, 1998.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mexiletine | Small molecule | — | Oral |